Axil Capital Launches its Second Life Science Fund (ALHF II)
Nov 9, 2022 - Axil Capital announced today the launch of Axil Life Science & Healthcare Fund II (“ALHF II”)
As with ALHF I, ALHF II will focus on investing and supporting life science and health-tech startups by leveraging its industry expertise and global network. The fund aims to produce world-class companies from Japan by liaising with the global venture ecosystem and enabling the venture managers to adopt a global perspective focused on commercial success.
＜Fund Summary＞
Name
：
Axil Life Science & Healthcare Fund II Investment Limited Partnership (ALHF II L.P.)
GP
：
Axil Capital Partners II Limited Liability Partnership
Target Area
：
Biopharmaceutical, Life Science, Medical Technology and Healthcare Technology
Target Regions
：
Primarily Japan, with diversification across U.S., EU and Asia
Target Stage
：
Diversified investments from seed/early to middle/later
© Axil Capital All Rights Reserved